Key Points
- Visa has a forward dividend yield of 0.8% and has increased its dividend by 379% over the past decade.
- Novartis has consecutively raised its dividends for 28 years, with a current yield of 2.8% and over 10 products generating annual sales of more than $1 billion.
- Meta Platforms, which initiated a dividend in 2024 with a yield of 0.3%, serves over 3.5 billion daily active users and leverages AI for enhanced advertising.
Visa, Novartis, and Meta Platforms have been highlighted as potential long-term investments due to their strong dividend track records and growth prospects. Visa processes credit and debit transactions, benefiting from a large network and significant growth in digital payments. Novartis maintains its position as a reliable pharmaceutical company with a robust product portfolio, while Meta leverages its extensive user base for digital advertising revenue and is increasingly integrating artificial intelligence.
